Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 7, 2019
CohBar Reports First Quarter 2019 Financial Results and Business Update
MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related ...
May 7, 2019
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
DUBLIN, Ireland, May 07, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage neuroscience company, today reported financial results for the first quarter of ...
May 7, 2019
BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations
RALEIGH, N.C., May 06, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with ...
May 7, 2019
MediWound Enters into Exclusive License Agreement with Vericel for Commercial Rights to NexoBrid® in North America
YAVNE, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe ...
May 7, 2019
RedHill Biopharma Submits New Drug Application for Talicia® for H. pylori Infection
TEL-AVIV, Israel and RALEIGH, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a ...
May 7, 2019
Kamada to Report First Quarter 2019 Financial Results and Host Conference Call on May 14
REHOVOT, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release ...
May 7, 2019
Zealand Pharma enrolls first patient in Phase 3 extension study of glepaglutide for treatment for short bowel syndrome
Copenhagen, May 7, 2019 – Zealand Pharma A/S (“Zealand”) (ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development ...
May 7, 2019
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results
TEL AVIV, Israel, May 7, 2019 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
May 7, 2019
RedHill Biopharma Reports First Quarter 2019 Financial Results and Operational Highlights
TEL-AVIV, Israel and RALEIGH, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a ...
May 7, 2019
BioLineRx Announces FDA Approval of IND Application for AGI-134, a Novel Immunotherapy Anti-Cancer Vaccine for Solid Tumors
TEL AVIV, Israel, May 7, 2019 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that the U.S. Food and Drug ...
May 7, 2019
Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights
AUSTIN, Texas, May 07, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that engineers next generation human enzymes to provide solutions ...
May 7, 2019
Actinium Announces Appointment of Niva Almaula, Ph.D. as Chief Business Officer
NEW YORK, May 7, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced the appointment of Niva Almaula, Ph.D. as Chief Business Officer, ...
May 7, 2019
InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14
TEL AVIV, Israel, May 07, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
May 7, 2019
iCAD Reports First Quarter 2019 Financial Results
NASHUA, N.H., May 07, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc.(ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported financial ...
May 7, 2019
Zogenix to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference
EMERYVILLE, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, ...
May 7, 2019
BioLineRx to Report First Quarter 2019 Results on May 14, 2019
TEL AVIV, Israel, May 7, 2019 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial ...
May 7, 2019
Acer Therapeutics to Present at UBS Global Healthcare Conference
NEWTON, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
May 7, 2019
CohBar Appoints Steven B. Engle as Chief Executive Officer
MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related ...
May 1, 2019
iCAD to Report First Quarter 2019 Financial Results on Tuesday, May 7
NASHUA, N.H., May 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc.(ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it ...
May 1, 2019
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued ...
Page 18 of 158